Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sugden, M. C.
Right arrow Articles by Holness, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sugden, M. C.
Right arrow Articles by Holness, M. J.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 50:2729-2736, 2001
© 2001 by the American Diabetes Association, Inc.

Selective Modification of Pyruvate Dehydrogenase Kinase Isoform Expression in Rat Pancreatic Islets Elicited by Starvation and Activation of Peroxisome Proliferator–Activated Receptor-{alpha}

Implications for Glucose-Stimulated Insulin Secretion

Mary C. Sugden, Karen Bulmer, Daniel Augustine, and Mark J. Holness

Department of Diabetes and Metabolic Medicine, Division of General and Developmental Medicine, St. Bartholomew’s and the Royal London School of Medicine and Dentistry, Queen Mary, University of London, London, U.K.

The pyruvate dehydrogenase complex (PDC) has a pivotal role in islet metabolism. The pyruvate dehydrogenase kinases (PDK1–4) regulate glucose oxidation through inhibitory phosphorylation of PDC. Starvation increases islet PDK activity (Am J Physiol Endocrinol Metab 270:E988–E994, 1996). In this study, using antibodies against PDK1, PDK2, and PDK4 (no sufficiently specific antibodies are as yet available for PDK3), we identified the PDK isoform profile of the pancreatic islet and delineated the effects of starvation (48 h) on protein expression of individual PDK isoforms. Rat islets were demonstrated to contain all three PDK isoforms, PDK1, PDK2, and PDK4. Using immunoblot analysis with antibodies raised against the individual recombinant PDK isoforms, we demonstrated increased islet protein expression of PDK4 in response to starvation (2.3-fold; P < 0.01). Protein expression of PDK1 and PDK2 was suppressed in response to starvation (by 27% [P < 0.01] and 10% [NS], respectively). We demonstrated that activation of peroxisome proliferator–activated receptor-{alpha} (PPAR-{alpha}) by the selective agonist WY14,643 for 24 h in vivo leads to specific upregulation of islet PDK4 protein expression by 1.8-fold (P < 0.01), in the absence of change in islet PDK1 and PDK2 protein expression but in conjunction with a 2.2-fold increase (P < 0.01) in islet PPAR-{alpha} protein expression. Thus, although no changes in islet PPAR-{alpha} expression were observed after the starvation protocol, activation of PPAR-{alpha} in vivo may be a potential mechanism underlying upregulation of islet PDK4 protein expression in starvation. We evaluated the effects of antecedent changes in PDK profile and/or PPAR-{alpha} activation induced by starvation or PPAR-{alpha} activation in vivo on glucose-stimulated insulin secretion (GSIS) in isolated islets. GSIS at 20 mmol/l glucose was modestly impaired on incubation with exogenous triglyceride (1 mmol/l triolein) (~20% inhibition; P < 0.05) in islets from fed rats. Starvation (48 h) impaired GSIS in the absence of triolein (by 57%; P < 0.001), but GSIS after the further addition of triolein did not differ significantly between islets from fed or starved rats. GSIS by islets prepared from WY14,643-treated fed rats did not differ significantly from that seen with islets from control fed rats, and the response to triolein addition resembled that of islets prepared from fed rather than starved rats. PPAR-{alpha} activation in vivo led to increased insulin secretion at low glucose concentrations. Our results are discussed in relation to the potential impact of changes in islet PDK profile on the insulin secretory response to lipid and of PPAR-{alpha} activation in the cause of fasting hyperinsulinemia.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
U. A. White, A. A. Coulter, T. K. Miles, and J. M. Stephens
The STAT5A-Mediated Induction of Pyruvate Dehydrogenase Kinase 4 Expression by Prolactin or Growth Hormone in Adipocytes
Diabetes, June 1, 2007; 56(6): 1623 - 1629.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. J. Holness, N. D. Smith, G. K. Greenwood, and M. C. Sugden
PPAR{alpha} activation reverses adverse effects induced by high-saturated-fat feeding on pancreatic beta-cell function in late pregnancy
Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1087 - E1094.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. J. Holness, G. K. Greenwood, N. D. Smith, and M. C. Sugden
Peroxisome Proliferator-Activated Receptor-{alpha} and Glucocorticoids Interactively Regulate Insulin Secretion During Pregnancy
Diabetes, December 1, 2006; 55(12): 3501 - 3508.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Ravnskjaer, M. Boergesen, B. Rubi, J. K. Larsen, T. Nielsen, J. Fridriksson, P. Maechler, and S. Mandrup
Peroxisome Proliferator-Activated Receptor {alpha} (PPAR{alpha}) Potentiates, whereas PPAR{gamma} Attenuates, Glucose-Stimulated Insulin Secretion in Pancreatic {beta}-Cells
Endocrinology, August 1, 2005; 146(8): 3266 - 3276.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. F. Horowitz, A. E. Kaufman, A. K. Fox, and M. P. Harber
Energy deficit without reducing dietary carbohydrate alters resting carbohydrate oxidation and fatty acid availability
J Appl Physiol, May 1, 2005; 98(5): 1612 - 1618.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. Bouche, S. Serdy, C. R. Kahn, and A. B. Goldfine
The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes
Endocr. Rev., October 1, 2004; 25(5): 807 - 830.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H.-S. Kwon, B. Huang, T. G. Unterman, and R. A. Harris
Protein Kinase B-{alpha} Inhibits Human Pyruvate Dehydrogenase Kinase-4 Gene Induction by Dexamethasone Through Inactivation of FOXO Transcription Factors
Diabetes, April 1, 2004; 53(4): 899 - 910.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. C. Sugden and M. J. Holness
Potential Role of Peroxisome Proliferator-Activated Receptor-{alpha} in the Modulation of Glucose-Stimulated Insulin Secretion
Diabetes, February 1, 2004; 53(90001): S71 - 81.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. C. Sugden and M. J. Holness
Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs
Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E855 - E862.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. C. Sugden, G. K. Greenwood, N. D. Smith, and M. J. Holness
Peroxisome Proliferator-Activated Receptor-{alpha} Activation during Pregnancy Attenuates Glucose-Stimulated Insulin Hypersecretion in Vivo by Increasing Insulin Sensitivity, without Impairing Pregnancy-Induced Increases in {beta}-Cell Glucose Sensing and Responsiveness
Endocrinology, January 1, 2003; 144(1): 146 - 153.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.